US FDA’s RTOR Program Produces Approvals About One Month Sooner Than Priority Review Goal

 
• By Bridget Silverman

Novel agents approved under Real-Time Oncology Review posted a median time to approval of seven months, our Pink Sheet RTOR infographic shows, while other RTOR applications had a median 4.5 month approval time.

FDA review times
• Source: Nielsen Hobbs; the Pink Sheet | Shutterstock, Getty images

More from US FDA Performance Tracker

More from Regulatory Trackers